Key result
Del Nido cardioplegia cuts mortality ~56% compared to cold blood cardioplegia.
Why the study?
Optimal cardioplegia selection remains controversial, and prior meta-analyses included fewer comparators and relied on frequentist methods unable to generate probabilistic rankings.
Does del Nido cardioplegia or other specific cardioplegia solutions improve clinical and procedural outcomes compared to Cold Blood or Cold Crystalloid cardioplegia in patients undergoing cardiac surgery?
Meta-Analysis (n=11,501)
Does del Nido cardioplegia or other specific cardioplegia solutions improve clinical and procedural outcomes compared to Cold Blood or Cold Crystalloid cardioplegia in patients undergoing cardiac surgery?
Answers are grounded in this paper and cite their sources.
This large Bayesian network meta-analysis demonstrates that while del Nido cardioplegia offers the best overall protection, optimal cardioplegia selection should be tailored to patient-specific factors such as cross-clamp duration and LVEF.
Introduction: Optimal cardioplegia selection remains controversial. Prior meta-analyses included fewer comparators and used frequentist methods that cannot generate probabilistic rankings. Methods: Systematic review (MEDLINE, Embase, CENTRAL, Wanfang, CKNI) and Bayesian NMA using gemtc/JAGS (200,000 iterations, 50,000 burn-in). We included 101 RCTs (11,501 patients) comparing Cold Blood (CB), Cold Crystalloid (CC), del Nido (DN), HTK/Custodiol, Warm Blood (WB), Tepid Blood (TB), and Microplegia (MP) across 14 outcomes (8 binary: mortality, MI, LCOS, IABP, inotropes, AF, stroke, spontaneous rhythm; 6 continuous: cross-clamp, CPB, ICU, ventilation, CK-MB, troponin). SUCRA rankings with corrected directionality and subgroup analyses by surgery type and clamp duration were performed. Results: Del Nido ranked first in 7/14 outcomes: mortality SUCRA 83.5%, AF 82.2%, spontaneous rhythm 91.0%, IABP 95.6%, cross-clamp 96.4%, ICU 73.9%, inotropes 71.1%. Twelve comparisons reached significance, including DN vs CB mortality (OR 0.44, 95%CrI 0.21-0.92), DN vs CC for AF (OR 0.18, 0.04-0.83), and HTK vs CC for stroke (OR 0.05, 0.003-0.79). Subgroup analysis revealed DN-to-HTK crossover at ~125-155 min clamp. Microplegia showed highest SUCRA for LCOS (82.1%) and ICU (88.8%) in patients with LVEF<35%. Conclusions: This NMA of cardioplegia demonstrates del Nido provides best overall protection but optimal selection is patient-specific: HTK for prolonged clamp >150min, MP for low-EF with renal dysfunction, WB for prior MI with COPD. One-size-fits-all cardioplegia should end.
No takes yet. Share an insight, caveat, or question.
Loaiza et al. (2026) conducted a meta-analysis in Cardiac surgery requiring cardioplegia (n=11,501). Del Nido cardioplegia (among 7 cardioplegia types) vs. Cold Blood, Cold Crystalloid, HTK/Custodiol, Warm Blood, Tepid Blood, and Microplegia was evaluated on Mortality (among 14 evaluated clinical and continuous outcomes) (OR 0.44, 95% CI 0.21-0.92). Del Nido cardioplegia ranked first in 7 of 14 outcomes, reducing mortality compared to Cold Blood.
Synapse has enriched 10 related papers. Consider them for comparative context: